Nifty

:

23250.10

Sensex

:

76295.36

-82.25 (-0.35%)
-322.08 (-0.42%)

Login

Nifty
Sensex

:
:

23250.10
76295.36

-82.25 (-0.35%)
-322.08 (-0.42%)

Yatharth Hospital & Trauma Care Services Ltd.

Hospital & Healthcare Services

Rating :

N/A

BSE: 543950 | NSE: YATHARTH

Watchlist

NSE BSE

444.55

06-Feb-2025

Open
High
Low
Previous Close

444.95
453.75
432.65
441.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

517163
2301.10
693.00
345.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,493.49
34.52
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,338.90
N/A
2.83

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
18.70

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
10.20

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
37.37

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 14.46 17.35 22.31 31.86
P/E Ratio 41.52 34.61 26.91 18.85
Revenue 671 910 1212 1780
EBITDA 180 234 303 409
Net Income 114 146 186 274
ROA 15.2 0.2 0.2 0.2
P/B Ratio 5.9 4.58 3.62 2.87
ROE 21.65 14.12 14.39 17.24
FCFF -93.33 -317.8 -47.06 35.54
FCFF Yield -1.85 -6.31 -0.93 0.71

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 110.41 101.73 8.53% 112.87 110.12 2.50% 118.96 102.34 16.24% 105.59 97.13 8.71%
Expenses 78.61 72.40 8.58% 82.21 78.83 4.29% 86.18 73.25 17.65% 78.00 69.37 12.44%
EBITDA 31.80 29.33 8.42% 30.66 31.29 -2.01% 32.78 29.09 12.68% 27.59 27.76 -0.61%
EBIDTM 28.80% 28.83% 27.16% 28.42% 27.56% 28.43% 26.13% 28.58%
Other Income 3.15 4.75 -33.68% 1.81 3.35 -45.97% 2.63 0.40 557.50% 5.06 0.35 1,345.71%
Interest 0.15 0.13 15.38% 0.21 1.57 -86.62% 0.11 2.42 -95.45% 0.19 2.37 -91.98%
Depreciation 5.19 3.97 30.73% 4.77 3.17 50.47% 4.00 3.16 26.58% 3.15 3.75 -16.00%
PBT 29.62 29.98 -1.20% 27.49 29.91 -8.09% 31.31 23.91 30.95% 29.32 21.98 33.39%
Tax 7.37 8.88 -17.00% 7.09 8.86 -19.98% 8.16 8.30 -1.69% 3.08 6.66 -53.75%
PAT 22.25 21.10 5.45% 20.40 21.04 -3.04% 23.15 15.61 48.30% 26.24 15.33 71.17%
PATM 20.16% 20.74% 18.07% 19.11% 19.46% 15.25% 24.85% 15.78%
EPS 2.31 2.19 5.48% 2.12 2.18 -2.75% 2.40 1.62 48.15% 2.72 1.59 71.07%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 219.16 166.79 31.40% 217.77 171.28 27.14% 211.78 154.51 37.07% 177.75 143.79 23.62%
Expenses 164.24 120.37 36.45% 163.13 125.71 29.77% 158.12 113.09 39.82% 131.22 105.32 24.59%
EBITDA 54.92 46.42 18.31% 54.63 45.57 19.88% 53.66 41.41 29.58% 46.53 38.47 20.95%
EBIDTM 25.06% 27.83% 25.09% 26.61% 25.34% 26.80% 26.18% 26.76%
Other Income 4.21 5.38 -21.75% 2.97 3.82 -22.25% 3.65 0.76 380.26% 5.66 0.68 732.35%
Interest 2.06 0.17 1,111.76% 1.56 2.94 -46.94% 2.92 5.93 -50.76% 0.38 5.95 -93.61%
Depreciation 16.91 7.85 115.41% 15.95 6.88 131.83% 11.44 6.87 66.52% 7.70 8.26 -6.78%
PBT 40.16 43.78 -8.27% 40.09 39.57 1.31% 42.96 29.37 46.27% 44.11 24.94 76.86%
Tax 9.66 14.29 -32.40% 9.14 11.97 -23.64% 12.57 10.33 21.68% 5.76 7.62 -24.41%
PAT 30.49 29.49 3.39% 30.95 27.60 12.14% 30.38 19.04 59.56% 38.35 17.32 121.42%
PATM 13.91% 17.68% 14.21% 16.12% 14.35% 12.32% 21.57% 12.05%
EPS 3.16 3.43 -7.87% 3.61 3.22 12.11% 3.54 2.91 21.65% 4.47 2.64 69.32%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 447.83 419.79 371.51 298.59 164.73 Net Sales Growth 8.88% 13.00% 24.42% 81.26% Cost Of Goods Sold 60.17 37.30 28.62 27.85 17.53 Gross Profit 387.66 382.49 342.90 270.74 147.20 GP Margin 86.56% 91.11% 92.30% 90.67% 89.36% Total Expenditure 325.00 300.88 265.18 213.56 122.55 Power & Fuel Cost - 7.74 7.39 8.58 5.75 % Of Sales - 1.84% 1.99% 2.87% 3.49% Employee Cost - 69.00 56.85 57.06 32.07 % Of Sales - 16.44% 15.30% 19.11% 19.47% Manufacturing Exp. - 140.72 115.13 81.45 49.93 % Of Sales - 33.52% 30.99% 27.28% 30.31% General & Admin Exp. - 39.57 55.41 34.08 17.16 % Of Sales - 9.43% 14.91% 11.41% 10.42% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% Miscellaneous Exp. - 6.56 1.78 4.55 0.11 % Of Sales - 1.56% 0.48% 1.52% 0.07% EBITDA 122.83 118.91 106.33 85.03 42.18 EBITDA Margin 27.43% 28.33% 28.62% 28.48% 25.61% Other Income 12.65 13.55 1.60 1.27 0.52 Interest 0.66 5.90 9.76 12.81 12.15 Depreciation 17.11 13.45 12.64 13.16 12.52 PBT 117.74 113.11 85.52 60.32 18.03 Tax 25.70 29.12 21.35 18.23 2.52 Tax Rate 21.83% 25.74% 24.96% 30.22% 13.98% PAT 92.04 83.99 64.17 42.09 15.50 PAT before Minority Interest 92.04 83.99 64.17 42.09 15.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.55% 20.01% 17.27% 14.10% 9.41% PAT Growth 25.94% 30.89% 52.46% 171.55% EPS 9.55 8.71 6.66 4.37 1.61

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 826.46 670.55 520.29 400.94 228.67 Net Sales Growth 29.87% 28.88% 29.77% 75.34% Cost Of Goods Sold 122.70 60.69 44.37 50.02 33.45 Gross Profit 703.76 609.86 475.93 350.92 195.23 GP Margin 85.15% 90.95% 91.47% 87.52% 85.38% Total Expenditure 616.71 488.55 385.13 288.96 160.62 Power & Fuel Cost - 14.63 13.71 12.19 9.33 % Of Sales - 2.18% 2.64% 3.04% 4.08% Employee Cost - 111.02 85.93 74.97 43.81 % Of Sales - 16.56% 16.52% 18.70% 19.16% Manufacturing Exp. - 231.38 171.76 102.44 52.76 % Of Sales - 34.51% 33.01% 25.55% 23.07% General & Admin Exp. - 59.51 65.53 43.36 20.06 % Of Sales - 8.87% 12.59% 10.81% 8.77% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% Miscellaneous Exp. - 11.31 3.84 5.99 1.22 % Of Sales - 1.69% 0.74% 1.49% 0.53% EBITDA 209.74 182.00 135.16 111.98 68.05 EBITDA Margin 25.38% 27.14% 25.98% 27.93% 29.76% Other Income 16.49 15.61 2.81 1.65 0.52 Interest 6.92 11.48 22.78 22.65 19.89 Depreciation 52.00 29.30 27.51 27.87 20.56 PBT 167.32 156.83 87.68 63.11 28.12 Tax 37.13 42.36 21.91 18.94 8.54 Tax Rate 22.19% 27.01% 24.99% 30.01% 30.37% PAT 130.17 114.47 65.77 44.16 18.16 PAT before Minority Interest 130.17 114.47 65.77 44.16 19.59 Minority Interest 0.00 0.00 0.00 0.00 -1.43 PAT Margin 15.75% 17.07% 12.64% 11.01% 7.94% PAT Growth 39.29% 74.05% 48.94% 143.17% EPS 13.50 11.87 6.82 4.58 1.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 836.99 176.13 111.71 71.89 Share Capital 85.85 65.52 65.52 16.38 Total Reserves 751.14 110.61 46.19 55.51 Non-Current Liabilities 7.83 82.79 85.08 95.20 Secured Loans 2.03 75.94 70.06 82.65 Unsecured Loans 0.00 0.00 0.00 1.60 Long Term Provisions 1.68 0.96 0.80 0.00 Current Liabilities 33.57 67.31 89.08 40.66 Trade Payables 11.61 10.80 16.09 13.08 Other Current Liabilities 21.91 46.68 51.57 27.58 Short Term Borrowings 0.00 9.78 15.21 0.00 Short Term Provisions 0.05 0.06 6.21 0.00 Total Liabilities 878.39 326.23 285.87 207.75 Net Block 132.52 120.63 122.38 125.68 Gross Block 248.25 222.92 212.03 197.47 Accumulated Depreciation 115.73 102.29 89.64 71.79 Non Current Assets 214.76 168.90 175.02 161.09 Capital Work in Progress 0.00 0.00 0.00 0.78 Non Current Investment 66.99 46.88 46.88 34.30 Long Term Loans & Adv. 10.02 1.32 5.53 0.22 Other Non Current Assets 5.24 0.06 0.23 0.11 Current Assets 663.62 157.34 110.85 46.66 Current Investments 0.00 0.00 0.00 0.00 Inventories 3.93 3.22 2.35 2.74 Sundry Debtors 143.45 85.83 76.33 32.86 Cash & Bank 227.01 12.74 1.83 0.63 Other Current Assets 289.23 8.54 2.14 0.15 Short Term Loans & Adv. 276.19 47.02 28.19 10.28 Net Current Assets 630.06 90.03 21.77 6.00 Total Assets 878.38 326.24 285.87 207.75

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 874.32 182.96 116.89 72.45 Share Capital 85.85 65.52 65.52 16.38 Total Reserves 788.47 117.45 51.37 56.08 Non-Current Liabilities 67.53 195.21 206.58 173.09 Secured Loans 61.00 200.59 207.38 163.47 Unsecured Loans 14.24 0.00 0.00 0.25 Long Term Provisions 2.54 1.30 0.98 0.04 Current Liabilities 67.22 99.52 97.11 55.00 Trade Payables 29.16 16.88 20.41 16.53 Other Current Liabilities 37.94 66.29 55.27 34.56 Short Term Borrowings 0.07 16.30 15.21 3.90 Short Term Provisions 0.05 0.06 6.21 0.01 Total Liabilities 1,009.07 477.69 420.58 308.77 Net Block 441.88 298.52 303.10 250.81 Gross Block 665.79 471.75 448.83 337.85 Accumulated Depreciation 223.91 173.23 145.73 87.03 Non Current Assets 498.82 301.42 311.17 259.45 Capital Work in Progress 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 33.78 1.79 6.84 7.27 Other Non Current Assets 23.16 1.11 1.23 1.37 Current Assets 510.25 176.27 109.40 49.32 Current Investments 0.00 0.00 0.00 0.00 Inventories 8.13 6.07 5.20 3.39 Sundry Debtors 227.00 107.64 85.54 36.77 Cash & Bank 238.64 38.44 12.08 5.15 Other Current Assets 36.48 12.23 2.14 0.00 Short Term Loans & Adv. 18.62 11.88 4.45 4.01 Net Current Assets 443.03 76.75 12.30 -5.68 Total Assets 1,009.07 477.69 420.57 308.77

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 15.96 25.58 26.80 23.76 PBT 113.11 85.52 60.32 18.03 Adjustment 5.91 21.33 25.08 24.16 Changes in Working Capital -67.26 -49.07 -49.25 -16.86 Cash after chg. in Working capital 51.77 57.78 36.15 25.32 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -35.80 -32.20 -9.34 -1.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -167.47 -8.66 -18.47 -5.71 Net Fixed Assets -25.33 -10.89 -13.78 Net Investments -20.11 0.00 -12.58 Others -122.03 2.23 7.89 Cash from Financing Activity 240.58 -6.25 -7.47 -18.71 Net Cash Inflow / Outflow 89.08 10.66 0.86 -0.65 Opening Cash & Equivalents 12.15 1.49 0.63 1.28 Closing Cash & Equivalent 101.23 12.15 1.49 0.63

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity -3.08 63.78 59.94 43.67 PBT 156.83 87.68 63.11 28.12 Adjustment 26.18 48.75 49.25 39.37 Changes in Working Capital -142.34 -35.25 -39.40 -21.57 Cash after chg. in Working capital 40.67 101.18 72.96 45.92 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -43.75 -37.40 -13.02 -2.25 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -225.87 -20.31 -52.17 -21.24 Net Fixed Assets -25.33 -10.89 -13.78 Net Investments -20.11 0.00 -12.58 Others -180.43 -9.42 -25.81 Cash from Financing Activity 304.21 -17.75 -1.12 -19.05 Net Cash Inflow / Outflow 75.26 25.73 6.64 3.38 Opening Cash & Equivalents 37.43 11.71 5.00 1.61 Closing Cash & Equivalent 112.70 37.43 11.71 5.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 97.49 26.88 17.05 10.97 ROA 13.95% 20.97% 16.92% 7.57% ROE 16.58% 44.59% 46.49% 24.18% ROCE 21.06% 37.32% 37.19% 17.47% Fixed Asset Turnover 1.78 1.71 1.44 0.84 Receivable days 99.68 79.66 66.01 56.70 Inventory Days 3.11 2.74 3.11 5.89 Payable days 109.67 171.47 189.52 252.41 Cash Conversion Cycle -6.88 -89.08 -120.39 -189.82 Total Debt/Equity 0.00 0.65 0.98 1.45 Interest Cover 20.17 9.76 5.71 2.48

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 101.84 27.93 17.84 11.06 ROA 15.40% 14.64% 12.11% 6.57% ROE 21.65% 43.87% 46.65% 30.91% ROCE 23.97% 26.88% 27.07% 19.30% Fixed Asset Turnover 1.18 1.13 1.03 0.77 Receivable days 91.08 67.76 55.67 42.83 Inventory Days 3.87 3.95 3.91 4.99 Payable days 138.44 153.39 134.80 165.15 Cash Conversion Cycle -43.49 -81.68 -75.22 -117.33 Total Debt/Equity 0.10 1.44 2.21 2.57 Interest Cover 14.66 4.85 3.79 2.41

Top Investors:

kotak mahindra trustee co ltd a/c kotak multicap fund

citigroup global markets mauritius private limited - odi

sbi life insurance co. ltd

bandhan small cap fund

jupiter india fund

east capital - east capital global emerging markets sustainable

Annual Reports:

News Update:

Yatharth Hospital and Trauma Care Services acquires 60% stake in MGS Infotech Research and Solutions
29th Mar 2025, 16:40 PM

The company will be starting the hospital operations soon
Read More
Yatharth Hospital - Quarterly Results
27th Jan 2025, 12:38 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback